T. Rowe Price Associates’s 9 Meters Biopharma, Inc. Common Stock NMTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,081
| Closed | -$6K | – | 3061 |
|
|
2022
Q2 | $6K | Buy |
1,081
+91
| +9% | +$505 | ﹤0.01% | 2940 |
|
|
2022
Q1 | $12K | Buy |
990
+274
| +38% | +$3.32K | ﹤0.01% | 2954 |
|
|
2021
Q4 | $14K | Sell |
716
-275
| -28% | -$5.38K | ﹤0.01% | 2964 |
|
|
2021
Q3 | $26K | Buy |
991
+75
| +8% | +$1.97K | ﹤0.01% | 2923 |
|
|
2021
Q2 | $20K | Buy |
+916
| New | +$20K | ﹤0.01% | 2908 |
|